Young adults experience lingering COVID symptoms too
A new preliminary study contradicts the perception that lingering COVID-19 symptoms mostly affect middle-aged adults...
Fellowships grants build industry connections
The University of Adelaide has been awarded over $2.5 million in funding to activate six innovative research projects as part of the Australian Research Council (ARC) Early Career Industry Fellowships scheme.
Call for ‘mindset shift’ from business as Waterside facility opened
The Waterside building is the new outstanding facility for our Business School, which opened to staff and students in September 2024.
Meet the students that broke the vending machine story
“It won’t get any bigger than this,” says River Stanley, a fourth-year University of Waterloo student in the Computer Science program...
Scientists find way to wipe a cell’s memory to better reprogram it as a...
In a groundbreaking study published in Nature , Australian scientists have resolved a long-standing problem in regenerative medicine.
Southampton launches citizens’ assembly to tackle climate change
A plan to create a citizens’ assembly in Southampton has been announced by City Council and University experts as part of efforts to tackle climate change and co-design a road to net-zero with nearby residents and businesses.
Ambitious Climate Action Pays Off
Action to mitigate climate change costs money – but damage caused by climate change also entails financial burdens, particularly for future generations. So how much action to mitigate climate change makes economic sense?
Call to end harmful marketing after study reveals children’s exposure
An end to outdoor marketing of gambling, alcohol and junk food is urgently needed to protect children from harm, according to new University of Otago-led research.
Reusable facemasks made using smartphones and 3D printers
Bespoke, reusable facemasks made using smartphones and 3D printers could help better protect people during future epidemics or further waves of Covid-19, new research suggests.
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.
